My Profile   |   Print Page   |   Contact Us   |   Sign In   |   Register
ASAP Blog
Blog Home All Blogs
Welcome to ASAP Blog, the best place to stay current regarding upcoming events, member companies, the latest trends, and leaders in the industry. Blogs are posted at least once a week; members may subscribe to receive notifications when new blogs are posted by clicking the "Subscribe" link above.

 

Search all posts for:   

 

Top tags: Alliance Management  alliances  collaboration  partnering  alliance  alliance managers  partners  alliance manager  partnerships  ecosystem  partner  The Rhythm of Business  governance  Jan Twombly  Strategic Alliance Magazine  Eli Lilly and Company  IoT  partnership  biopharma  NetApp  Vantage Partners  2015 ASAP Global Alliance Summit  ASAP BioPharma Conference  Cisco  Healthcare  strategy  Digital Transformation  IBM  innovation  Jeff Shuman 

The Next Wave in Collaboration? Lessons from Platform Ecosystems, Part 1: From Alliance Lifecycle Phases to ‘Minimum Viable Partnerships’

Posted By Contributed by Ard-Pieter de Man, CSAP, PhD, Wednesday, January 9, 2019

In my recent Q4 2018 Strategic Alliance Quarterly article about the emerging profession of the ecosystem manager, I mentioned that the most extreme examples of ecosystem management were found around platform organizations like Facebook and Apple. These platform-based ecosystems provide a glimpse into the future of alliance management. In fact, the future may already be here—and not just in information technology. At the November 8-9, 2018 ASAP European Alliance Summit, I heard about some fascinating examples of pharma companies that build platforms, use artificial intelligence, and connect an increasing variety of ecosystem partners. Other cases are easy to find: John Deere, not exactly a Silicon Valley start-up, and Signify (previously Philips Lighting) are examples of long-established companies that discovered that the mix of platforms and ecosystems holds great promise. What inspiration can we draw from the way these companies manage their ecosystems?

To answer that question, I focus on three characteristics of platform ecosystems.

  • First, the high speed of developments around platforms. As a consequence of that speed, partnerships need to be set up rapidly and must be easy to dissolve.
  • Second, increased unpredictability of new developments, because of the high diversity of technologies and business models that are introduced into the market.
  • Third, an increase in the number of partners, including many partnerships that are not traditional alliances.

Many existing alliance best practices do not fit well with these characteristics of ecosystems. To deal with them, new best practices are emerging that require us to rethink some of the classic tenets of alliance management. I will discuss four of them.

The Alliance Lifecycle: From Phases to “Minimum Viable Partnerships”

The alliance lifecycle has been one of the foundations of alliance management for more than twenty years. The lifecycle divides the process of alliance management into distinct steps:

  • setting the alliance-specific strategy
  • partner selection
  • negotiation
  • planning
  • structuring and governance
  • launching and managing
  • transformation

This structured process has proved to be very effective. It gives managers an alliance-building framework that ensures relevant issues are dealt with in the right order.

It has one huge drawback, though, in an ecosystem world: it is slow. It may take over a year before all the steps are covered. A second problem is that following all these steps in a strict order makes it difficult to adjust an alliance to changing circumstances. The alliance lifecycle assumes an alliance can be relatively stable for a longer time period and requires episodic instead of continuous change. In an ecosystem world, however, alliances may be in a continuous state of transformation.

Instead of using the alliance lifecycle, alliances may be seen as start-ups that evolve continuously and rapidly. Hence proposals begin to emerge to use the lean start-up methodology for alliances. At the 2018 ASAP European Alliance Summit, Jan Twombly, CSAP, president of The Rhythm of Business, showed how to adapt the firm’s “rhythm of business” methodology—in essence, how to use lean start-up methods—to create “minimum viable partnerships” that do not go at length through all the elements of the alliance lifecycle. This allows for fast partnering and continuous adaptation, and provides an alternative for the alliance lifecycle.

Ard-Pieter de Man, CSAP, PhD, is professor of management studies at the School of Business and Economics of the Vrije Universiteit Amsterdam. A longtime ASAP member, he also is a consultant to companies and not-for-profits. Part Two of this three-part blog series discusses how traditional alliance diagnostics make way for real-time monitoring of partner (or ecosystem) health.

ASAP Media encourages diversity of thought and opinion as partnering practice and the profession of alliance management continually expand and evolve. To contribute your voice to the conversation, on this or other seminal topics relating to business collaboration, please contact John W. DeWitt, editor and publisher of ASAP Media and Strategic Alliance magazines, at 646-232-6620 or jdewitt@asapmedia.org.

Tags:  alliance  alliance-specific strategy  Ard-Pieter de Man  ASAP European Alliance Summit  ASAP Strategic Alliance Quarterly  governance  John Deere  launching  managing  negotiation  partner selection  Philips Light  planning  structuring  traditional alliance diagnostics  transformation  Vrije Universiteit Amsterdam 

Share |
PermalinkComments (0)
 

‘Like Putting Together a Puzzle’: IBM Execs Tackle Cyber Security Concerns of Multi-Party Alliances in 2018 ASAP Tech Partner Forum Keynote

Posted By Cynthia B. Hanson, Friday, November 2, 2018
Updated: Wednesday, October 31, 2018

Threat factors are a growing concern for alliance managers coordinating multi-party, multi-industry collaborations. They need to consider the potential new channels created by their complexity, such as shared information and data. That message was woven into the keynote address “Cyber Security Ecosystem Meets the Customer Experience” presented by Mitch Mayne, public information officer at IBM, and Wendi Whitmore, global lead for IBM’s X-Force Incident Response and Intelligence Services (IRIS), at the 2018 ASAP Tech Partner Forum, “Reimaging Part­nering in a Disruptive World,” on October 17, at the Four Points by Sheraton, San Jose Airport, San Jose, California.

IBM has streamlined two separate cyber security response teams: one that deals with major security breaches and another that focuses on threat intelligence, detection, and response. The teams are oriented toward both internal and external communications in the event of a major pandemic cyber attack, the speakers explained. IBM is partnering extensively with more than 200 companies on cyber security response “through shared relationships with private and public companies,” explained Mayne. “Cyber security is a lot like putting together a puzzle. No one team has all the pieces. Our system helps us better protect clients and ourselves, and increases the speed of response.”

He then introduced IBM’s Cyber Range, an immersive, lifelike environment, based in Cambridge, Massachusetts, for simulating a breach. The Cyber Range teaches about appropriate, timely responsiveness by taking attendees through an actual breach that includes answering multiple ringing phone calls from the press and FBI. The program drives home the importance of having an integrated plan and a responsive, educated company culture.

The hand’s on teaching tool includes actual technology that “responders would be using. What the range is really fast at is increasing communications and awareness between groups,” Whitmore said.

Best practices are shared between teams, such as coordinating the split-second communication needs of executives with the slower pace of tech teams, which must compile and analyze large volumes of data. For example, the C-suite needs to understand why it could take four hours or even three days to assess data, she explained further. “It really increases perspective, and we have seen organizations really transformed by the process.”

It’s about building a cyber security culture within the company, Mayne added. Additionally, the Cyber Range instructs on the dos and don’ts of how and what to communicate to the press, clients, and internally: “How do you manage them during a breach?” He then provided some tips:

  • Have a holding statement prepared in advance that could cover a variety of incidents and you can release at a moment’s notice.
  • Let employees know ahead of time what is acceptable to say and do.
  • Do not speculate: Release only factual information and shows you have command of the situation.

In October, IBM plans to unveil the next level of the Cyber Range.  The Mobile Range will visit the National Mall in Washington, D.C., universities on the US east coast, and Europe in January.

During the Q&A session, an attendee described having just signed a multi-party contract with extensive language on cyber security response responsibilities.

“You have to ask your partners, ‘Do you have a plan in place if something like this were to happen?’” Mayne replied.

In another question, someone pointed out that compartmentalization helps with security, but then asked, “How do we partner and make sure these things are worked through?”

“Compartmentalization has created a lot of the problem,” replied Whitmore. “The more you can have increased communication between the stakeholders, the better your chance that you can quickly work through these scenarios.”

See more of the ASAP Media team’s coverage of the 2018 ASAP Tech Partner Forum on the ASAP Blog at www.strategic-alliances.org. Learn more about the 2018 ASAP Tech Partner Forum at http://asaptechforum.org

Tags:  2018 ASAP Tech Partner Forum  Channels  communication  Customer Experience Mitch Mayne  Cyber Security  Disruptive World  Ecosystem  IBM  IRIS  Mobile Range  partner  partnering  shared information and data  stakeholders  Wendi Whitmore  X-Force Incident Response and Intelligence Service 

Share |
PermalinkComments (0)
 

The C-Suite Takes Front Seat in Lively Panel Discussion at ASAP BioPharma Conference (Part 3)

Posted By Cynthia B. Hanson, Thursday, November 1, 2018
Updated: Wednesday, October 31, 2018

This is a continuation from the panel discussion “Speak My Language: How to Have a High Impact Conversation with the C-suite,” which took place at the 2018 ASAP BioPharma Conference. See Part 1 of this blog post for background information on the panel, which included:

  • James C. Mullen, chairman of the board of directors at Editas Medicine, Inc., who has grown many organizations dependent on partnerships
  •   Samantha Singer, chief operating officer at the Broad Institute, whose organization partners with multiple industries to achieve the Institute’s mission to impact human health throughout the world
  • Alex Waldron, chief commercial officer at Pear Therapeutics, who is highly skilled at bringing in business development and alliance management expertise to grow a company through partnerships

Christine Carberry, CSAP, chief operating officer at Keryx Biopharmaceuticals, moderated the session. At this point in the discussion, Carberry had just prompted panel members to answer the following: “Let’s dig into where things tend to go awry. How do alliance professionals demonstrate their value to the organization? The second half of my question is, what are some of the pitfalls? Where do alliances get in trouble, and how can an alliance manager avoid those pitfalls?” After listening to the responses (see Part 2 of this blog for panelists’ answers), she added her thoughts.

Carberry: Build C-suite-to-C-suite [connections] early on in the relationship. I use to joke that it’s important to have relationships between companies that play golf so the CEOs can get together. You need to be comfortable getting on the phone with them and having a conversation that can go like this: “This is what we’ve done, tried, and this is why it didn’t work.” This is helpful to an executive. We need to implement what will remove barriers and allow us to go forward. The value proposition may have just changed for the companies: That beautiful future might not get created, because we all know divorce is part of the deal. One of the things you will discover as an alliance manager is  you will get people in the organization grumbling about the partner.

Mullen: How many of you inherited a contact, and you were not at the table? [At this point, nearly everyone raised his or her hand while laughter rippled through the room.] Look for the wishy-washy language. Those are the issues that never got resolved during the contract negotiations.

Singer: No matter how good your business development is, the reality is [your perception of the contract] will not match three months later.

Mullen: If you are talking about “stage gate,” make sure it means the same thing between the partners. It may seem really obvious, but it’s not. Make exactly sure of what they are saying.

Carberry: Have clear definitions. For example, “First Patient In.” You may think things are commonly understood, but lawyers say it’s important to make sure definitions are as clear as they possibly can be.

Carberry then fielded an audience question from Jeremy Ahouse, CSAP, vice president alliances, Merus. “A lot of alliance people complain that when they have to bring bad news, the C-suite thinks they only bring problems. How can you do that so that the messenger doesn’t feel like they will get shot?”

Mullen: You need a fairly straight scorecard for the goals of the partnership, and you need a record against that. That way,  it becomes evident that you are making progress. The fact is, [otherwise], you are just raising problems. Check off the problems, and let them know that they talked to you about it, that work was done, and here’s how it got resolved. Keep a high-level scorecard.

Waldron: I agree on the scorecard. And talk about successes, don’t only talk about problems.

Carberry: Everyone is conditioned to success. So if you are doing your job well, you are having those conversations about problems with us.

Waldron: If your company doesn’t have some kind of periodic review, push for that—even if it’s a 15-minute review. Push for that so you can get in front of them. We had a lot of customers, and both the customers and our company didn’t do everything perfectly. But when I had that review of information first, then when they called me up and let me know, 90 percent of the problem was already solved. I knew about it, cared about it, and it got solved.

See parts one and two of this blog and ASAP Media’s ongoing coverage from the 2018 ASAP BioPharma Conference on the ASAP Blog at www.strategic-alliances.org. You will find interviews with conference presenters and other coverage of leadership and strategy, biopharma-tech partnerships, and other trending conference topics in recent and forthcoming editions of Strategic Alliance Magazine and eSAM Plus

Tags:  Alex Waldron  alliance managers  Broad Institute  Christine Carberry  collaborations  c-suite  Editas Medicine  James C. Mullen  Keryx Biopharmaceuticals  partnerships  Pear Therapeutics  Samantha Singer  scorecard 

Share |
PermalinkComments (0)
 

The C-Suite Takes Front Seat in Lively Panel Discussion at ASAP BioPharma Conference (Part 2)

Posted By Cynthia B. Hanson, Wednesday, October 31, 2018

This article continues ASAP Media’s coverage of the panel discussion “Speak My Language: How to Have a High Impact Conversation with the C-suite,” which took place September 25 at the 2018 ASAP BioPharma Conference in Boston. After introducing the panel members (see Part 1 of this blog post for background information on the panelists), Christine Carberry, CSAP, chief operating officer at Keryx Biopharmaceuticals, prompted the panel members to answer the following: “Let’s dig into where things tend to go awry. How do alliance professionals demonstrate their value to the organization? The second half of my question is, what are some of the pitfalls? Where do alliances get in trouble, and how can an alliance manager avoid those pitfalls?”

Samantha Singer, chief operating officer at the Broad Institute: Alliance managers demonstrate their value in their ability to escalate appropriately and bring issues to senior management. We don’t always understand where relationships are going to stumble when we go around the corner. Where I’ve seen situations fall down is when alliance managers think they need to solve problems first; coming to the senior executive when there’s something wrong without ideas for how to solve it. Also, treat the relationship as a relationship. Make sure the transactional doesn’t get in the way of the relationship for you and the entire team. The last point is: Keep the conversations honest. When people are collaborating together, someone usually wants to impress someone else or know more. But we all know, on projects, that is not how you get things done: Tackle problems, and be creative. And make sure that honest dialog really happens.

James C. Mullen, chairman of the board of directors at Editas Medicine, Inc.: Understand whoever is running around the C-suite, they only know so much. You need to decide what they need to know. The tendency is to over-communicate. I’ve received 40-page project reports that I never read. I only care about the problems. Focus on escalating the exceptions. That’s what I need to know about. The best way to get my attention is: Don’t try to tell me everything as if I am on the same level as you are. If you dump those 40 pages in my in-box, they never get read. Escalate it, and escalate it quickly. If there is an issue, highlight it and tell me what the implication of this issue is. I want to hear ideas on how to solve the problem. Finally, I want to know if you need help from me to work on a problem. Those are my four steps. The last thing is: You need to know the details of the contract. And if the realities of the partnership are drifting to someplace else, you need to address that contractually. If they drift too far, then you are in a no-mans land of who-was-supposed-to-do-what.

Alex Waldron, chief commercial officer at Pear Therapeutics: I am empathetic in one area: You are the people who need to implement the contract that has just been written. You’ve got to translate the three million pages into what it means for the company and get that going forward. The quickest way to do this is to create as much transparency as you possibly can with the partners out there. Alliances are like marriages: When you get married, you are star struck. It’s a wonderful idea that is almost never accurate. As both companies grow, the priorities will change over time: Your job is to remind everyone of that. Don’t use the “E” wordEscalate. Try to understand the alliance manager on the other side of the table, and create as much transparency as you can, even if it means saying “I understand why you are saying ‘no’ to me, but I must insist based on this contract….”  Managing the contract is absolutely critical. To ensure the success of the contract is essential to avoid pitfalls.

See recent and forthcoming editions of eSAM Plus and Strategic Alliance Magazine and revisit the ASAP Blog at www.strategic-alliances.org for continuing, comprehensive ASAP Media team coverage of the 2018 ASAP BioPharma Conference. 

Tags:  Alex Waldron  alliance managers  Broad Institute  Christine Carberry  collaborations  c-suite  Editas Medicine  James C. Mullen  Keryx Biopharmaceuticals  partnerships  Pear Therapeutics  Samantha Singer 

Share |
PermalinkComments (0)
 

The Rugged Biopharma/Tech Topography—What Alliance Managers Need to Know (Part 2)

Posted By Cynthia B. Hanson, Wednesday, October 24, 2018
Updated: Tuesday, October 23, 2018

This extremely well-organized session, “Non-traditional Partnerships:  The Changing BioPharma Alliance Landscape and the Implications for the Alliance Professional and Alliance Management Community” held by Stu Kliman and Ben Siddall of Cambridge-based Vantage Partners, started off by outlining the multiple challenges the biopharma industry faces today, many of which are financial. One major solution to those challenges lies in building more relationships across the lifecycle, specifically with tech, the pair pointed out. They described the complex ecosystem of partnerships that are emerging today and how to determine if it’s right for your company to jump into the trend and/or continue to engage in multi-partner collaborations. Also on the docket was a discussion on effective partnering, which requires the capability to make good choices and the ability to execute.

All major biopharma companies are following the route of building a greater partnering base, they explained. Some of the deals are very large—in the hundreds of millions. Some involve very big players that are exploring and investing in the digital health tech space, such as Apple and IBM. Some are much smaller, or combine large and small companies. No matter the size of the companies involved, when entering the field, “You need to be purposeful and execute quickly,” explained Siddall.

And you need to consider “What makes relationships work—what are the leverage points?” added Kliman.  “As we think about this new landscape of partnering, we are already seeing our clients making mistakes.”

One of the really important areas where companies are struggling in this ecosystem is the process of thinking through whether they should be partnering at all. “Should we just have a vendor relationship? What does partnership mean? Through what process are we making that decision? Where does partnering make sense?” said Kliman, ticking off the kinds of questions that naturally emerge.

“To achieve maximum value, biopharmas must select the right partners to address specific needs and manage these relationships in a way that acknowledges these differences,” Kliman emphasizes. It’s very important in the process to consider the differences between pharma and tech, he said, while flashing a slide.

The pharma cycle has:

  • High levels of regulation
  • Very long (five-plus years) “product” development
  • Management and investors familiar with longer development
  • Purposeful and predictable innovation and co-creation
  • Strong functional stakeholders (medical, legal, compliance, finance)
  • Contractual, asset-based alliances with fixed lengths
  • Well-defined commercial negotiation models with “customers” with significant regulation

The tech cycle has:

  • Variability—many markets are not regulated
  • Short to moderate (1-3 years) “product” development
  • Management/investors who tend to expect quick ROI and steady growth
  • Rapid and agile innovation and co-creation
  • Moderate or weak functional stakeholders (legal, compliance, finance)
  • A blend of formal/informal alliances, often with no fixed length
  • Flexible, market-driven customer engagement processes

Also of great importance is the process of thinking through the best possible partner choices and evaluating them according to the meta-criteria of capabilities. Both presenters recommend considering the marketplace and size of the deals and evaluating potential partners from multiple dimensions that go beyond just the financial impact. Vantage recommends doing this with a four-quadrant methodology that analyzes strategic, financial, operational, and relational fits.

“On the back end, we have challenges during execution to consider,” Kliman added. “Pharma and IT are significantly different. If your core expertise is to identify and manage alliance models that manage different partners, that needs to be brought into upstream activities as well.”

“If you are going to enter into this new world, you want to make sure the relationship is purposeful,” Kliman added. A purposeful relationship contains the following criteria, he said. It should be:

  • Purposeful (focused on a well-defined market; meets patient, partner, and company needs)
  • Choiceful (partnership is worth the effort; has the right answer, among other things)
  •  Designed and developed collaboratively (based on a shared vision; focused on joint gain, among other things)
  • Actively managed (with joint oversight; systems reviews; robust metrics)
  • Building over time
  • Assessed

See part one of this session coverage blog and stay tuned for more ASAP Media team coverage from the 2018 ASAP BioPharma Conference. 

Tags:  alliance  Ben Siddall  healthcare landscape  licensing-type alliance groups  partnering  pharma  Stu Kliman  tech  Vantage Partners 

Share |
PermalinkComments (0)
 
Page 2 of 73
1  |  2  |  3  |  4  |  5  |  6  |  7  >   >>   >| 
For more information email us at info@strategic-alliances.org or call +1-781-562-1630